>> 全站文章索引 >> 第32页:
  • Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs). - [Keene MS, Eaddy MT, Mauch RP, Regan TS, Shah M, Chiao E]
  • Impaired platelet [(3)H]paroxetine binding in female patients with borderline personality disorder. - [Ng Ying Kin NM, Paris J, Schwartz G, Zweig-Frank H, Steiger H, Nair NP]
  • Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses - [Golding M, Kotlyar M, Carson SW, Hoyler S, Lazarus C, Davidson C, Guzzo J, Sontz E, Garbutt JC]
  • Paroxetine (Paxil) and congenital malformations - [Megan Williams, Eric Wooltorton]
  • Electric Sensations: Neglected Symptom of Escitalopram Discontinuation - [Nadia Feth, Katja Cattapan-Ludewig, Eveline Jaquenoud Sirot]
  • Trimipramine for Refractory Panic Attacks - [Domingo Cerra]
  • Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. - [Kennedy SH, Andersen HF, Lam RW]
  • The Relevance of Pharmacokinetic Studies in Designing Efficacy Trials in Juvenile Major Depression - [Robert L. Findling, Nora K. McNamara, Robert J. Stansbrey, Norah C. Feeny, Christopher M. Young, Franco V. Peric, Eric A. Youngstrom]
  • Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants - [Andrew D. Mosholder, Carol A. Pamer]
  • Evaluation of Suicidal Thoughts and Behaviors in Children and Adolescents Taking Paroxetine - [Alan Apter, Alan Lipschitz, Regan Fong, David J. Carpenter, Stan Krulewicz, John T. Davies, Christel Wilkinson, Philip]
  • An International, Multicenter, Placebo-Controlled Trial of Paroxetine in Adolescents with Major Depressive Disorder - [Ray Berard, Regan Fong, David J. Carpenter, Christine Thomason, Christel Wilkinson]
  • Sexual function during bupropion or paroxetine treatment of major depressive disorder. - [Kennedy SH, Fulton KA, Bagby RM, Greene AL, Cohen NL, Rafi-Tari S]
  • Digitalis intoxication induced by paroxetine co-administration - [Norio Yasui-Furukori, Sunao Kaneko]
  • Persistent pulmonary hypertension of the newborn and maternal use of SSRIs - [Eric Wooltorton]
  • Antidepressants for the Treatment of Neuropathic Pain - [William E Cayley JR]
  • A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients. - [Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M]
  • Medicaid Coverage of Newer Psychotropic Medication - [Meenakshi Venkataraman]
  • Paroxetine treatment of primary insomnia in older adults. - [Reynolds CF 3rd, Buysse DJ, Miller MD, Pollock BG, Hall M, Mazumdar S]
  • Impact of prior treatment exposure on response to antidepressant treatment in late life. - [Tew JD Jr, Mulsant BH, Houck PR, Lenze EJ, Whyte EM, Miller MD, Stack JA, Bensasi S, Reynolds CF 3rd]
  • 阿司匹林和丙戊酸钠：相关性血浆蛋白位移药物交互作用 - [Neil B Sandson, Catherine Marcucci, Denis L Bourke, Rosemary Smith-Lamacchia. The American Journal of Psychiatry. Washington:]
  • 认知行为疗法与帕罗西汀治疗的疑病：随机对照试验 - [Anja Greeven, Anton J L M van Balkom, Sako Visser, Jille W Merkelbach, et al. The American Journal of Psychiatry. Washington:]
  • 替代性的选择性血清素再吸收抑制剂氟西汀和帕罗西汀对酒精依赖的影响 - [S. Maurel, Rudy Schreiber, Jean De Vry]
  • 具有约束力的相关性与复发的自杀行为的 血小板羟色胺和[ 3 H ]帕罗西汀结合点研究 - [R. J. Verkes, Durk Fekkes, Aeilko H. Zwinderman, Michiel W. Hengeveld, Rose C. Van der Mast, Jolien P. Tuyl, Ad. J. F. M. Kerkhof, Godfried M. J. Van Kempen]
  • 亚帕罗西汀治疗的健康受试者睡眠脑电图的微观结构分析 - [J. R?schke, P. K?gel, R. Schl?sser, P. Wagner, K. Mann, W. Rossbach, O. Benkert]
  • 帕罗西汀与奈法唑酮对5 - HT1A受体敏感性影响 - [P. Sargent, D. J. Williamson, G. Pearson, J. Odontiadis, P. J. Cowen]
  • 文拉法辛，帕罗西汀与地昔帕明瞳孔光反射男子的效果比较 - [P. Bitsios, E. Szabadi, C. M. Bradshaw]
  • 单剂量奈法唑酮与帕罗西汀在5-HT2A结合位点的影响 - [J. H. Meyer, R. Cho, S. Kennedy, S. Kapur]
  • 文拉法辛和帕罗西汀对羟色胺的传输在人类志愿者的急性影响 - [Richard J. Porter, R. Hamish McAllister-Williams, A. H. Young]
  • 舍曲林，氟西汀，帕罗西汀不同的微分强化的低rate72 -第二操作性附表中的作用的不同影响 - [J. D. Sokolowski, L. S. Seiden]
  • 帕罗西汀辅助三环类抗抑郁药对焦虑住院病人血清水平和毒副作用的影响 - [S. Leucht, H. -J. Hackl, W. Steimer, D. Angersbach, R. Zimmer]
  • 帕罗西汀为特定恐惧症的双盲安慰剂对照研究 - [J. Benjamin, I. Z. Ben-Zion, E. Karbofsky, P. Dannon]
  • 药物治疗的“旋转木马” - [Kathryn Brown]
  • 前额羟色胺耗竭后的认知僵化 - [H. F. Clarke, J. W. Dalley, H. S. Crofts, T. W. Robbins, and A. C. Roberts]
  • 强硬的安慰剂规则让科学家冷淡 - [Cassio Leite Vieira]
  • 抑郁症的治疗前途光明 - [Constance Holden]
  • 披露临床试验的儿童 - [Maurizio Bonati, Chiara Pandolfini, and Antonio Clavenna]
  • 奖励在P物质的坚持研究 - [Claes Wahlestedt]
  • 磷酸化和螯合羟色胺转运差异调制精神刺激 - [Sammanda Ramamoorthy and Randy D. Blakely]
  • FDA评价服用抗抑郁药的孩子的自杀率 - [Constance Holden]
  • DRUG SAFETY:Conflict-of-Interest Allegations Derail Inquiry Into Antidepressant's 'Dark Side' - [Daniel Bachtold]
  • 抗抑郁药活性P物质受体中央的独特机制 - [Mark S. Kramer, Neal Cutler, John Feighner, Ram Shrivastava, John Carman, John J. Sramek, Scott A. Reines, Guanghan Liu, Duane Snavely, Edwina Wyatt-Knowles, Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Christopher J. Swain, Timothy Harrison, Raymon]
  • 隐藏的数据可能危害公司的健康 - [Eliot Marshall]
  • 8-OH-DPAT而不是deramciclane对抗anxiogenic-like帕罗西汀高度紊乱 - [Sulev K?ks, Sergei Beljajev, Indrek Koovit, Urho Abramov, Michel Bourin, Eero Vasar]
  • 选择性血清素再吸收抑制剂帕罗西汀在广义焦虑症比非广义焦虑症更有效 - [Dan J. Stein, Murray B. Stein, Wendy Goodwin, Rajinder Kumar, Brian Hunter]
  • 长期帕罗西汀治疗侵略性和冲动反应成年男性品行障碍影响 - [Don R. Cherek, Scott D. Lane, Cynthia J. Pietras, Joel L.]
  • 帕罗西汀对胞外羟色胺和额叶多巴胺水平的影响 - [Kazuhiko Nakayama]
  • 吲哚洛尔对缓解帕罗西汀引起的大鼠腹侧海马5-羟色胺释放减少的胞体树突作用:一项微透析研究 - [Jesús M. Míguez, Lucinda Paz-Vali?as, Isabel Míguez, Manuel Aldegunde]
  • 吲哚洛尔，帕罗西汀及其联合作用对健康受试者的睡眠结构的影响 - [Caroline Bell, Sue Wilson, Ann Rich, Jayne Bailey, David Nutt]
  • 帕罗西汀在母乳喂养：婴儿体重增加和产妇的影响 - [Paul Merlob, Bracha Stahl, Jaqueline Sulkes]
  • 帕罗西汀没有加重额颞痴呆病人的认知障碍：一项随机双盲研究 - [J.B. Deakin, S. Rahman, P.J. Nestor, J.R. Hodges, B.J. Sahakian]
  • 帕罗西汀剂量及cyp2d6 -突变的等位基因对血浆浓度的影响 - [Kazushi Sawamura, Yutaro Suzuki, Toshiyuki Someya]
  • 帕罗西汀联合5 -羟色胺A受体拮抗剂在安非他明减量期间的异常 - [Athina Markou, Amanda A. Harrison, Jessica Chevrette, Daniel Hoyer]
  • 由强迫产生的偷窥癖和裸露癖：帕罗西汀的临床效应 - [Ahmed Abouesh, Anita Clayton]
  • 在β -环糊精包含抗抑郁药帕罗西汀 - [Mino R. Caira, Elise De Vries, Luigi R. Nassimbeni, Victor W. Jacewicz]
  • 舍曲林，帕罗西汀，文拉法辛治疗创伤后应激障碍伴随抑郁症状 - [Amer Smajkic, Stevan Weine, Zvezdana Djuric-Bijedic, Esad Boskailo, Jonathan Lewis, Ivan Pavkovic]
  • 一项测试盐酸帕罗西汀在治疗乳腺癌幸存者时控热效果的评估实验 - [V. Stearns, C. Isaacs, J. Rowland, J. Crawford, M. J. Ellis, R. Kramer, W. Lawrence, J. J. Hanfelt, D. F. Hayes]
  • 帕罗西汀，氟西汀和安慰剂在门诊病人抑郁症治疗的双盲研究 - [.]
  • 患有抑郁症的乳腺癌病人的治疗：帕罗西汀和阿米替林的对比研究 - [G. Pezzella, R. Moslinger-Gehmayr, A. Contu]
  • 用盐酸帕罗西汀治疗接受化疗的乳腺癌病人疲劳和抑郁症的效果 - [Joseph A. Roscoe, Gary R. Morrow, Jane T. Hickok, Karen M. Mustian, Jennifer J. Griggs, Sara E. Matteson, Peter Bushunow, Raman Qazi, Brian Smith]
  • 3H米帕明和3H帕罗西汀在大脑具有高度亲和力位点的区域分布 - [P. Rosel, J. M. Menchon, M. Oros, J. Vallejo, T. Cortadellas, B. Arranz, P. Alvarez, M. A. Navarro]
  • 服用帕罗西汀的病人色氨酸转运子增加——一项SPECT研究 - [Ana M. Catafau, Victor Perez, Pedro Plaza, Juan-Carlos Pascual, Santiago Bullich, Marina Suarez, Maria M. Penengo, Iluminada Corripio, Dolors Puigdemont, Monica Danus, Javier Perich, Enric Alvarez]
  • 特比萘芬能使口服帕罗西汀的健康人血液浓度增加 - [Norio Yasui-Furukori, Manabu Saito, Yoshimasa Inoue, Takenori Niioka, Yasushi Sato, Shoko Tsuchimine, Sunao Kaneko]
  • 急性与慢性抗抑郁药治疗对记忆表现的影响——帕罗西汀与丙咪嗪对比 - [Laurent Naudon, Ma?té Hotte, Thérèse M. Jay]
  • Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay - [Noé Jurado, Carlos Torner, Gerhard Heinze, Guadalupe López, José Mendoza-Sotelo, Alejandro Lazo-Langner and Julia Moreno]
  • A direct entry to substituted piperidinones from α,β-unsaturated amides by means of aza double Michael reaction - [Kiyosei Takasu, Naoko Nishida and Masataka Ihara]
  • Correlation of subjective and objective sleep measurements at different stages of the treatment of depression - [Spilios V. Argyropoulos, Jane A. Hicks, Jon R. Nash, Caroline J. Bell, Ann S. Rich, David J. Nutt and Susan J. Wilson]
  • Cerebrovascular Disease and Late-Life Depression - [Mast, Benjamin T.]
  • Depression and Other Mental Health Diagnoses Increase Mortality Risk After Ischemic Stroke - [Williams, Linda S.; Ghose, Sushmita Shoma; Swindle, Ralph W.]
  • Depression-Executive Dysfunction Syndrome in Stroke Patients - [Vataja, Risto M.; Pohjasvaara, Tarja M.; Mantyla, Riitta M.; Ylikoski, Raija Ph; Leskela, Maarit M.; Kalska, Hely Ph; Hietanen, Marja Ph; Juhani, Aronen Hannu; Salonen, Oili M.; Kaste, Markku M.; Leppavuori, Antero M.; Erkinjuntti, Timo M.]
  • Symptom Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients - [Spalletta, Gianfranco M.; Ripa, Alessandra B.; Caltagirone, Carlo M.]
  • Comparison of the Effects of Citalopram and Escitalopram on 5-Ht-Mediated Neuroendocrine Responses - [Haitham S Nadeem, Mary-Jane Attenburrow and Philip J Cowen]
  • Serotonin and Dopamine Transporter Availabilities Correlate with the Loudness Dependence of Auditory Evoked Potentials in Patients with Obsessive-Compulsive Disorder - [Oliver Pogarell1, Klaus Tatsch2, Georg Juckel1, Christine Hamann2, Christoph Mulert1, Gabriele P?pperl2, Malte Folkerts1, Martina Choukèr2, Michael Riedel1, Michael Zaudig3, Hans-Jürgen M?ller1 and Ulrich Hegerl1]
  • Electrophysiological Evidence for the Tonic Activation of 5-HT1A Autoreceptors in the Rat Dorsal Raphe Nucleus - [Nasser Haddjeri1, Normand Lavoie2 and Pierre Blier2]
  • Inflamed brains can trigger the blues, studies suggest - [Gunjan Sinha]
  • Relationship of Mania Symptomatology to Maintenance Treatment Response with Divalproex, Lithium, or Placebo - [Charles L Bowden1, Michelle A Collins2, Susan L McElroy3, Joseph R Calabrese4, Alan C Swann5, Richard H Weisler6,7 and Patricia J Wozniak2]
  • Social, Psychological, and Psychiatric Interventions Following Terrorist Attacks: Recommendations for Practice and Research - [Edna B Foa1, Shawn P Cahill1, Joseph A Boscarino2, Stevan E Hobfoll3,4, Mooli Lahad5,6, Richard J McNally7 and Zahava Solomon8]
  • nnovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology - [Jan van der Greef, Robert N. McBurney]
  • The Selective 5-HT2A Receptor Antagonist M100907 Enhances Antidepressant-Like Behavioral Effects of the SSRI Fluoxetine - [Gerard J Marek1, Raul Martin-Ruiz2, Allyson Abo1 and Francesc Artigas2]
  • Regarding Pooh / The authors respond / Editors' note - [Julie Downs, Leslie Blumenberg, JoAnn Schuh, Stephen Black, et al]
  • Lifestyle drugs: Issues for debate - [Joel Lexchin]
  • Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression - [Sidney H Kennedy, Kenneth P Evans, Stephanie Kruger, Helen S Mayberg, et al]
  • Paroxetine in Child and Adolescent Outpatients with Panic Disorder - [Gabriele Masi, Cristina Toni, Maria Mucci, Stefania Millepiedi, Belen Mata, Giulio Perugi]
  • An exploratory study: The use of paroxetine for methamphetamine craving - [Anne Dekeyne, Alain Gobert, Agnès Auclair, Sylvie Girardon, Mark J. Millan]
  • Difficult people getting along - [Larry Greenbaum]
  • Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory - [M. van Laar, E. Volkerts, M. Verbaten, S. Trooster, et al. Psychopharmacology. New York: Aug 2002.Vol.162, Iss. 4; pg. 351]
  • The Gerbil Elevated Plus-Maze I: Behavioral Characterization and Pharmacological Validation - [Geoffrey B Varty, Cynthia A Morgan, Mary E Cohen-Williams, Vicki L Coffin, Galen J Carey]
  • 米帕明和帕罗西汀在自杀人群大脑结合部位的高亲和力 - [P. Rosel, B. Arranz, J. Vallejo, M. Oros, J. M. Menchón, P. Alvarez, M. A. Navarro]
  • 一种研究帕罗西汀抗抑郁作用的时间过程及其与吲哚洛尔相互作用的数学模型 - [Berangere Gruwez, Alain Dauphin, Michel Tod]
  • 帕罗西汀对抗利尿激素分泌异常综合征的影响 - [Takeshi Kubota, Akimasa Miyata]
  • 一种即时的固态萃取-液相色谱-串联质谱分析法分析西酞普兰、氟伏沙明和帕罗西汀在人体血液中的表现 - [M. Kollroser, C. Schober]
  • 强迫症与大脑活动的联系 - [.]
  • 抗抑郁药可恢复大脑视觉神经 - [.]
  • PTSD对慢性疼痛和抑郁症的影响 - [.]
  • 大脑区域活性降低或易患强迫症 - [.]
  • 延长暴露治疗法有助于预防创伤後应激障碍 - [.]
  • 大脑中复合胺含量过低容易导致过激行为 - [.]
  • 大脑某一区域可能与强迫症有关 - [.]
  • 调查显示：女性抑郁症患者的比例远远高于男性 - [.]
  • 华盛顿时报:游戏瘾将纳入美国精神疾病范畴 - [.]
  • 跨文化脑成像研究新进展 - [.]


    • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 [32] 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50